Immuron (IMRN) Net Margin (2016 - 2024)
Immuron (IMRN) recorded quarterly Net Margin of 63.56% in Q4 2024, up 27.78% quarter-over-quarter from 88.01% in Q4 2023, and up 2445.0% on a YoY basis from 2.5% in Q1 2024.
Immuron (IMRN) Net Margin (2016 - 2024) Analysis & Trends
Immuron's Net Margin history runs 9 years deep, the most recent figure standing at 63.56% for Q4 2024.
- In Q4 2024, Net Margin rose 2445.0% year-over-year to 63.56%; the TTM figure through Dec 2024 stood at 63.56% (down 3426.0% YoY), while the FY2025 annual figure was 71.58%, up 6991.0% from the prior year.
- Net Margin was 63.56% for Q4 2024 at Immuron, up from 88.01% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 313.07% in Q4 2022 to a low of 386591061.41% in Q4 2020.
- Historically, Net Margin has averaged 64432196.28% across 5 years, with a median of 436.16% in 2021.
- The sharpest annual moves came in 2020 and 2021: Net Margin slumped 2000000000 bps in 2020, then soared 2000000000 bps in 2021.
- A 5-year view of Net Margin shows it stood at 386591061.41% in 2020, then soared by 100 bps to 784.3% in 2021, then surged by 140 bps to 313.07% in 2022, then tumbled by 128 bps to 88.01% in 2023, then increased by 28 bps to 63.56% in 2024.
- The last three Net Margin figures came in at 63.56% (Q4 2024), 88.01% (Q4 2023), and 1493.47% (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -63.56% |
| Dec 31, 2023 | -88.01% |
| Jun 30, 2023 | -1,493.47% |
| Dec 31, 2022 | 313.07% |
| Dec 31, 2021 | -784.30% |
| Dec 31, 2020 | -386,591,061.41% |
| Dec 31, 2019 | -97.73% |
| Dec 31, 2018 | -161.71% |
| Dec 31, 2017 | 535.91% |
| Dec 31, 2016 | 482.10% |
| Jun 30, 2016 | -379.89% |